Behind The Ugly Numbers From The Compliance Crisis Fallout: China Big Pharma Roundup
This article was originally published in PharmAsia News
Executive Summary
Compliance probes cooled pharma marketing in China, and the sales growth of the top 10 Big Pharma dropped to 1% from 18%.